We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Smartphones Could Diagnose Diseases Using Infrared Scans

By LabMedica International staff writers
Posted on 31 Mar 2025

Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor. More...

This innovative approach to personalized medicine and disease diagnostics is being driven by groundbreaking research at Georgia State University (Atlanta, GA, USA).

A research team at Georgia State University is pioneering non-invasive, accessible medical diagnostics through the use of ATR-FTIR spectroscopy, which stands for attenuated total reflectance-Fourier transform infrared spectroscopy. This technique allows for the examination of the molecular composition of materials by using infrared light to uncover minute details that are typically not visible. Applied to medical diagnostics, this technology enables the early detection of diseases like melanoma through an infrared scan. The research has already shown considerable promise in improving diagnostic capabilities for various conditions, earning patents for the detection of melanoma, lymphoma, colitis, and other forms of cell activation.

Currently, the team is focusing on tracking disease progression. Their latest research aims to measure how a disease develops over time, identifying key milestones that could eventually be used in clinical environments. This type of diagnostic technology could, for example, be used to assess the effectiveness of a specific treatment, allowing doctors to make timely adjustments. The main advantage of ATR-FTIR spectroscopy is its ability to provide precise molecular data and track disease progression without requiring invasive procedures. The researchers aim to embed this technology into everyday devices, enabling individuals to monitor their health from home, and eliminating the need to visit a clinic. According to scientists, these advancements can potentially revolutionize how we diagnose a wide range of illnesses, from common colds to colon cancer.

“In 10 to 15 years, I hope to see this technology in your smartphone, and in your everyday life,” said Regents’ Professor of Physics Unil Perera who is leading the team. “Imagine being able to take your own health readings from the comfort of your home. The potential for early detection and personalized medicine is enormous.”

Related Links:
Georgia State University


Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Gold Member
Latex Test
SLE-Latex Test
New
Respiratory Infections Test
STANDARD Q Adeno Respi Ag Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.